
STAT+: More Medicare plans cover Humira biosimilars, but do little to encourage patient use
Medicare drug plans significantly boosted coverage of biosimilar versions of the Humira rheumatoid arthritis medicine this year, but nearly all of them failed to take steps that would encourage greater use of these alternative treatments, a new government …